In the past few years we have heard many announcements - such as today's - about scaling up plans and programs regarding HIV/AIDS treatment. They have come from UNAIDS, WHO, PAHO and the Global Fund, as well as generic and originator drug companies. But after the press coverage dies down, things don't seem to change very much for the people who need these drugs.
[The following statement on "Strengthening Partnerships" was made at the January Board meeting by Milly Katana, board member representing South-NGOs, on behalf of the two NGO delegations and the Communities Living with HIV/TB/Malaria delegation.]
The issue of partnership has been raised here at the meeting on numerous occasions. And for good reason. It is at the core of our credo of "doing business differently".
[In Issue 2 of the GFO Newsletter (www.aidspan.org/gfo/archives/newsletter/issue2.htm), GFO reported that the Ugandan Ministry of Finance had ruled that an approved $52 million Global Fund grant from Round 1 will not be allowed to lead to an increase in Uganda's health expenditure.
Following are brief excerpts from contributions to Postings Four to Six of the GFO Discussion Forum. The views expressed do not necessarily reflect those of GFO or Aidspan.